Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC   US4525361055

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
02/20/2015 02/23/2015 02/24/2015 02/25/2015 02/26/2015 Date
0.556(c) 0.569(c) 0.5645(c) 0.5914(c) 0.5884(c) Last
932 037 698 129 512 449 2 632 944 845 399 Volume
0.00% +2.34% -0.79% +4.77% -0.51% Change
More quotes
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company, which focuses on developing immune-based therapies for the treatment of brain and other cancers.Its cell-based vaccine technologies are primary platform technologies and commercial prospects will be heavily dependent on the... 
More about the company
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -10,5 M
Net income 2014 -10,1 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -16,7 M
Net income 2015 -16,6 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 51,5 M
More Financials
Latest news on IMMUNOCELLULAR THERAPEUTIC
02/19 IMMUNOCELLULAR THERAPEUTICS : Announces Pricing of a Public Offering of Common S..
02/19 IMMUNOCELLULAR THERAPEUTICS : Strengthens Executive Management Team with Appoint..
02/18 IMMUNOCELLULAR THERAPEUTICS : Strengthens Executive Management Team with Appoint..
02/12 IMMUNOCELLULAR THERAPEUTICS : Announces Pricing of a Public Offering of Common S..
01/28 IMMUNOCELLULAR THERAPEUTICS : to Present at the BIO CEO & Investor Conference on..
2014 IMMUNOCELLULAR THERAPEUTICS : Html pdf
2014 IMMUNOCELLULAR THERAPEUTICS : Announces Issuance of Key Patent For ICT-107 Cance..
2014 IMMUNOCELLULAR THERAPEUTICS : gets EMA positive regulatory feedback on advancing..
More news
Sector news Biotechnology & Medical Research - NEC
08:01a QUINTILES TRANSNATIONAL : CEO to Present at Barclays Global Healthcare Conferenc..
02/26 QUINTILES TRANSNATIONAL : Where Pharmaceutical Companies are Heading: Complement..
02/26 INCYTE : Sponsors First Observational Study Designed to Understand the Impact of..
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF